Quarterly report · Q1
3353.TEDINET S100U1RT
Period2024-03-01 → 2024-05-31
Filed2024-07-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥11.2bn | 2024-03-01 → 2024-05-31 | Cons. | Net sales |
| Revenue | ¥39.9bn | 2023-03-01 → 2024-02-29 | Cons. | Net sales (5-year summary) |
| Revenue | ¥8.7bn | 2023-03-01 → 2023-05-31 | Cons. | Net sales |
| Operating income | ¥429m | 2024-03-01 → 2024-05-31 | Cons. | Operating income |
| Operating income | ¥294m | 2023-03-01 → 2023-05-31 | Cons. | Operating income |
| Ordinary income | ¥431m | 2024-03-01 → 2024-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2023-03-01 → 2024-02-29 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥338m | 2023-03-01 → 2023-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥671m | 2024-03-01 → 2024-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥375m | 2023-03-01 → 2023-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥429m | 2024-03-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.0bn | 2023-03-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥212m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥436m | 2024-03-01 → 2024-05-31 | Cons. | Profit loss |
| Net income | ¥224m | 2023-03-01 → 2023-05-31 | Cons. | Profit loss |
| Total assets | ¥31.8bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥31.7bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥28.1bn | at 2023-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥17.6bn | at 2024-05-31 | Cons. | Liabilities |
| Total liabilities | ¥17.8bn | at 2024-02-29 | Cons. | Liabilities |
| Net assets / equity | ¥14.2bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥13.8bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥12.7bn | at 2023-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.9bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.7bn | at 2024-02-29 | Cons. | Cash and deposits |
| EPS (basic) | ¥114.23 | 2024-03-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥276.7 | 2023-03-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.42 | 2023-03-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.7% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.2% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 44
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2024-03-01 → 2024-05-31 | −¥204m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-03-01 → 2024-05-31 | −¥204m |
| Reconciling Itemsreconciling | segment profit | 2024-03-01 → 2024-05-31 | −¥58m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥5.8bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥5.8bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥311m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥1.9bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥3.6bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥3.4bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥202m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥94m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2024-03-01 → 2024-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2024-03-01 → 2024-05-31 | ¥45m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2024-03-01 → 2024-05-31 | ¥32m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-03-01 → 2024-05-31 | ¥11.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-03-01 → 2024-05-31 | ¥11.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-03-01 → 2024-05-31 | ¥204m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-03-01 → 2024-05-31 | ¥487m |
| Reconciling Itemsreconciling | revenue | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-03-01 → 2023-05-31 | −¥277m |
| Reconciling Itemsreconciling | segment profit | 2023-03-01 → 2023-05-31 | −¥141m |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥5.9bn |
| jpcrp040300-q1r_E03443-000Dispensing Pharmacyreportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥329m |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥2.0bn |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥150,000 |
| jpcrp040300-q1r_E03443-000Health Carereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥50m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥1.1bn |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥810m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥275m |
| jpcrp040300-q1r_E03443-000Medical Products Wholesalereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥23m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue | 2023-03-01 → 2023-05-31 | ¥47m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue external | 2023-03-01 → 2023-05-31 | ¥46m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥1m |
| jpcrp040300-q1r_E03443-000Real Estatereportable segment | segment profit | 2023-03-01 → 2023-05-31 | ¥34m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-03-01 → 2023-05-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-03-01 → 2023-05-31 | ¥8.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-03-01 → 2023-05-31 | ¥277m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-03-01 → 2023-05-31 | ¥435m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 364
| Item | Context | Value | Unit |
|---|---|---|---|
| Income taxes deferred | Prior1YTDDuration | -69060000 | JPY |
| Income taxes deferred | CurrentYTDDuration | -77592000 | JPY |
| Income taxes | Prior1YTDDuration | 150645000 | JPY |
| Income taxes | CurrentYTDDuration | 235873000 | JPY |
| Profit loss | Prior1YTDDuration | 223900000 | JPY |
| Profit loss | CurrentYTDDuration | 435574000 | JPY |
| Profit loss attributable to non controlling interests | Prior1YTDDuration | 11927000 | JPY |
| Profit loss attributable to non controlling interests | CurrentYTDDuration | 6247000 | JPY |
| Profit loss attributable to owners of parent | Prior1YTDDuration | 211973000 | JPY |
| Profit loss attributable to owners of parent | CurrentYTDDuration | 429326000 | JPY |
| Profit loss | Prior1YTDDuration | 223900000 | JPY |
| Profit loss | CurrentYTDDuration | 435574000 | JPY |
| Valuation difference on available for sale securities net of tax oci | Prior1YTDDuration | -54623000 | JPY |
| Valuation difference on available for sale securities net of tax oci | CurrentYTDDuration | 3084000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -1267000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | 101000 | JPY |
| Other comprehensive income | Prior1YTDDuration | -55890000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 3186000 | JPY |
| Comprehensive income | Prior1YTDDuration | 168010000 | JPY |
| Comprehensive income | CurrentYTDDuration | 438761000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 156072000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 432527000 | JPY |
| Comprehensive income attributable to non controlling interests | Prior1YTDDuration | 11937000 | JPY |
| Comprehensive income attributable to non controlling interests | CurrentYTDDuration | 6233000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember | 5910452000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember | 1955093000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember | 810432000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember | 45974000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 8721952000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 8721952000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember | 150000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember | 275231000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember | 1163000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 276545000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -276545000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember | 5910452000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember | 1955243000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember | 1085664000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember | 47137000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 8998498000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -276545000 | JPY |
| Net sales | Prior1YTDDuration | 8721952000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E03443-000DispensingPharmacyReportableSegmentsMember | 329017000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E03443-000HealthCareReportableSegmentsMember | 49876000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E03443-000MedicalProductsWholesaleReportableSegmentsMember | 22768000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E03443-000RealEstateReportableSegmentsMember | 33731000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 435394000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |